All Posts

Faecal microbiota transplant has moved from fringe curiosity to one of the most studied therapies in gastroenterology. What the evidence actually says in 2026: cure rates above 90 per cent in recurrent C. difficile, antibiotic-FMT combination protocols for ulcerative colitis, a modest but real signal in IBS, and a rapidly expanding frontier in depression, bipolar disorder, and autism — alongside the multi-modal, multi-donor Shore protocol that reflects where the science has l

IBS is still too often dismissed as a diagnosis of exclusion treated with a pamphlet, an antispasmodic, and a low-FODMAP handout. In reality it is a biologically driven condition sitting at the intersection of the microbiome, diet, the gut-brain axis, visceral hypersensitivity, and psychology. This is the full map — from excluding serious disease through symptom relief, dietary and microbiome work, to faecal transplant and the cellular frontier of confocal endomicroscopy.

Reflux is one of the most common complaints in gastroenterology and one of the most misunderstood. Not all reflux is acid, not all reflux causes heartburn, and not all reflux responds to the first PPI prescribed. This is a deep but readable guide to the full spectrum of reflux disease — severity grades, Barrett's oesophagus, bile and non-acid reflux, motility disorders, and the diagnostic and treatment toolkit from lifestyle through vonoprazan to anti-reflux surgery.

Bowel cancer is one of the most common cancers in Australia and one of the most preventable. The difference between a routine screening test and a preventable death is often a single well-timed colonoscopy. This is a clear, evidence-based guide to who should be screened, with what test, and how often — from average risk through to strong family history, previous polyps, and inflammatory bowel disease.